news

[split_line_heading animation_type=”default”]

Enhancing Survival Through Innovative Immune Modulation

[/split_line_heading]

We are a late-stage clinical company developing microbiome therapies to modulate the immune system and improve cancer survival.

[divider line_type=”No Line” custom_height=”20″][nectar_btn size=”jumbo” button_style=”see-through-2″ color_override=”#ffffff” hover_color_override=”#ffffff” hover_text_color_override=”#000000″ icon_family=”none” text=”See News” url=”#press” margin_left=”0″ margin_right=”36″]
[page_submenu alignment=”center” link_color=”#014f90″][page_link title=”Corporate profile” id=”1746622987450-1″ tab_id=”1746622987451-3″ link_url=”#corpo”][/page_link][page_link link_url=”#press” title=”Press Releases” id=”1746622987466-5″ tab_id=”1746622987467-8″] [/page_link][page_link title=”Media Coverage” id=”1746622987471-0″ tab_id=”1746622987472-8″ link_url=”#media”][/page_link][page_link link_url=”#posters” title=”Posters” id=”1746622987476-10″ tab_id=”1746622987477-2″] [/page_link][page_link title=”Videos” id=”1746622987479-9″ tab_id=”1746622987480-2″ link_url=”#videos”][/page_link][/page_submenu]
[split_line_heading animation_type=”line-reveal-by-space” font_style=”h2″ text_color=”#5bc0cc” content_alignment=”default” mobile_content_alignment=”inherit” text_content=”Corporate profile”][/split_line_heading]

We are a leading, late-stage clinical company focused on developing innovative gut microbiome-driven therapies to modulate the immune system and enhance cancer patient survival. Supported by a talented team committed to making a difference for patients worldwide, the Company was founded in 2014 and is based in Lyon, France.
As a pioneer, MaaT Pharma has reached a major milestone in its development in January 2025, with positive topline results from its Phase 3 clinical trial evaluating its microbiome-driven immunomodulator in oncology. Using its proprietary pooling and co-cultivation technologies, MaaT Pharma develops high diversity, standardized drug candidates, aiming at extending life of cancer patients. MaaT Pharma has been listed on Euronext Paris (ticker: MAAT) since 2021.

[split_line_heading animation_type=”line-reveal-by-space” font_style=”h2″ text_color=”#5bc0cc” content_alignment=”default” mobile_content_alignment=”inherit” text_content=”Press Releases”][/split_line_heading][recent_posts style=”list_featured_first_row” columns=”1″ category=”press-releases” order=”DESC” orderby=”date” image_loading=”default” posts_per_page=”5″][nectar_cta btn_style=”see-through” heading_tag=”h3″ text_color=”#5bc0cc” button_color=”default” link_type=”regular” alignment=”left” alignment_tablet=”default” alignment_phone=”default” display=”block” text=”See more” url=”https://maat.swebwp.oci.eu/category/press-releases/”]
[split_line_heading animation_type=”line-reveal-by-space” font_style=”h2″ text_color=”#5bc0cc” content_alignment=”default” mobile_content_alignment=”inherit” text_content=”Media Coverage”][/split_line_heading][recent_posts style=”list_featured_first_row” columns=”1″ category=”media” order=”DESC” orderby=”date” image_loading=”default” posts_per_page=”6″][nectar_cta btn_style=”see-through” heading_tag=”h3″ text_color=”#5bc0cc” button_color=”default” link_type=”regular” alignment=”left” alignment_tablet=”default” alignment_phone=”default” display=”block” text=”See more” url=”https://maat.swebwp.oci.eu/category/media/”][recent_posts style=”list_featured_first_row” columns=”1″ category=”videos” order=”DESC” orderby=”date” image_loading=”default” posts_per_page=”6″]
[split_line_heading animation_type=”line-reveal-by-space” font_style=”h2″ text_color=”#5bc0cc” content_alignment=”default” mobile_content_alignment=”inherit” text_content=”Posters”][/split_line_heading][recent_posts style=”list_featured_first_row” columns=”1″ category=”posters” order=”DESC” orderby=”date” image_loading=”default” posts_per_page=”6″]